STAT1 and lung cancer: As shown in Fig. 3I–K, treatment with either Fludarabine or Stattic significantly reduced the viability of co-cultured Calu-1 cells after CAP treatment compared to those without inhibitor treatment, indicating that the activation of STAT1/STAT3 signal pathway in lung cancer cells was involved in the protection of macrophages.